Trial of Delgocitinib 20 mg/g Cream in Subjects With Frontal Fibrosing Alopecia (FFA)
NCT07671157
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Frontal Fibrosing Alopecia
Interventions
DRUG:
Delgocitinib
Sponsor
Maryanne Makredes Senna